Purpose
to develop an IPV vaccine adjuvanted with CAF01 that is able to enhance mucosal immunity and promote dose-sparing
Grantee
Division
Global Health
Date
NOVEMBER 2011
Region served
GLOBAL
Committed amount
$326,293
Grant topic
Discovery and Translational Sciences
Duration (months)
20
Grantee location
Copenhagen S., Hovedstaden, Denmark
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.